Apigenin supplementation protects the development of dextran sulfate sodium-induced murine experimental colitis by inhibiting canonical and non-canonical inflammasome signaling pathways

Journal of Nutritional Biochemistry

Volumn 30, Issue , 2016, Pages 143-152

  Márquez Flores, Yazmín K ^a,b   Villegas, Isabel ^b   Cárdeno, Ana ^b   Rosillo, M Ángeles ^b   Alarcón de la Lastra, Catalina ^b  

^a INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^b UNIVERSITY OF SEVILLE   (Spain)

Author keywords

Apigenin; Caspases; Chronic colitis; DSS; Inflammasome

Indexed keywords

APIGENIN; CYCLOOXYGENASE 2; DEXTRAN SULFATE; INDUCIBLE NITRIC OXIDE SYNTHASE; INFLAMMASOME; INTERLEUKIN 18; INTERLEUKIN 1BETA; STROMELYSIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DIET SUPPLEMENTATION; DISEASE SEVERITY; DOWN REGULATION; EXPERIMENTAL COLITIS; FEMALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED; COLITIS; DRUG EFFECTS;

ANIMALS; APIGENIN; COLITIS; DEXTRAN SULFATE; FEMALE; INFLAMMASOMES; MICE; MICE, INBRED C57BL; SIGNAL TRANSDUCTION;

EID: 84962106536     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2015.12.002     Document Type: Article

References (55)

1. Rubin D.C., Shaker A., Levin M.S. Chronic intestinal inflammation: inflammatory bowel disease and colitis-associated colon cancer. Front Immunol 2012, 3:1-10.
2. Dothel G., Vasina V., Barbara G., De Ponti F. Animal models of chemically induced intestinal inflammation: predictivity and ethical issues. Pharmacol Ther 2013, 139(1):71-86.
3. Sánchez-Hidalgo M., Martín A.R., Villegas I., C.A.D.L.L. Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, reduces chronic colonic inflammation in rats. Biochem Pharmacol 2005, 69(12):1733-1744.
4. Martín A.R., Villegas I., Sánchez-Hidalgo M., de la Lastra C.A. The effects of resveratrol, a phytoalexin derived from red wines, on chronic inflammation induced in an experimentally induced colitis model. Br J Pharmacol 2006, 147(8):873-885.
5. Wang D., Dubois R.N. Eicosanoids and cancer. Nat Rev Cancer 2010, 10(3):181-193.
6. van de Veerdonk F.L., Netea M.G., Dinarello C.A., Joosten L.A. Inflammasome activation and IL-1β and IL-18 processing during infection. Trends Immunol 2011, 32(3):110-116.
7. Kanai T., Kamada N., Hisamatsu T. Clinical strategies for the blockade of IL-18 in inflammatory bowel diseases. Curr Drug Targets 2013, 14(12):1392-1399.
8. Chen G.Y., Núñez G. Inflammasomes in intestinal inflammation and cancer. Gastroenterology 2011, 141(6):1986-1999.
9. Aguilera M., Darby T., Melgar S. The complex role of inflammasomes in the pathogenesis of inflammatory bowel diseases - lessons learned from experimental models. Cytokine Growth Factor Rev 2014, 25(6):715-730.
10. Ciraci C., Janczy J.R., Sutterwala F.S., Cassel S.L. Control of innate and adaptative immunity by the inflammasome. Microbes Infect 2012, 14(14):1263-1270.
11. Moll M., Kuemmerle-Deschner J.B. Inflammasome and cytokine blocking strategies in autoinflammatory disorders. Clin Immunol 2013, 147(3):242-275.
12. Broz P., Monack D.M. Noncanonical inflammasomes: caspase-11 activation and effector mechanisms. PLoS Pathog 2013, 9(2):e1003144.
13. Kang J., Zhao D., Teng K., Jiao X., Wang P., Sun Z., et al. Dramatic changes of matrix metalloproteinases-7 and lysozyme in the ulcerative colitis of mice induced by dextran sulfate sodium. J Integr Agr 2014, 13(4):858-869.
14. Opheim R., Bernklev T., Fagermoen M.S., Cvancarova M., Moum B. Use of complementary and alternative medicine in patients with inflammatory bowel disease: results of a cross-sectional study in Norway. Scand J Gastroenterol 2012, 47(12):1436-1447.
15. Rosillo M.A., Sánchez-Hidalgo M., Cárdeno A., Aparicio-Soto M., Sánchez-Fidalgo S., Villegas I., et al. Dietary supplementation of an ellagic acid-enriched pomegranate extract attenuates chronic colonic inflammation in rats. Pharmacol Res 2012, 66(3):235-242.
16. Cárdeno A., Sánchez-Hidalgo M., Alarcón-de-la-Lastra C. An up-date of olive oil phenols in inflammation and cancer: molecular mechanisms and clinical implications. Curr Med Chem 2013, 20(37):4758-4776.
17. Yan J., Yu L., Xu S., Gu W., Zhu W. Apigenin accumulation and expression analysis of apigenin biosynthesis relative genes in celery. Sci Hortic 2014, 165:218-224.
18. Zhang Y.-H., Park Y.-S., Kim T.-J., Fang L.-H., Ahn H.-Y., Hong J.T., et al. Endothelium-dependent vasorelaxant and antiproliferative effects of apigenin. Gen Pharmacol 2002, 35(6):341-347.
19. Siddique Y.H., Beg T., Afzal M. Antigenotoxic effect of apigenin against anti-cancerous drugs. Toxicol in Vitro 2008, 22(3):625-631.
20. Ali F., Rahul N.F., Jyoti S., Siddique Y.H. Protective effect of apigenin against N-nitrosodiethylamine (NDEA)-induced hepatotoxicity in albino rats. Mutat Res Genet Toxicol Environ Mutagen 2014, 767:13-20.
21. Funakoshi-Tago M., Nakamura K., Tago K., Mashino T. Anti-inflammatory activity of structurally related flavonoids, apigenin, luteolin and fisetin. Int Immunopharmacol 2011, 11(9):1150-1159.
22. Ganjare A.B., Nirmal S.A., Patil A.N. Use of apigenin from Cordia dichotoma in the treatment of colitis. Fitoterapia 2011, 82(7):1052-1056.
23. Mascaraque C., González R., Suárez M.D., Zarzuelo A., Sánchez de Medina F., Martínez-Augustin O. Intestinal anti-inflammatory activity of apigenin K in two rat colitis models induced by trinitrobenzenesulfonic acid and dextran sulphate sodium. Br J Nutr 2015, 113(4):618-626.
24. Bento A.F., Leite D.F., Marcon R., Claudino R.F., Dutra R.C., Cola M., et al. Evaluation of chemical mediators and cellular response during acute and chronic gut inflammatory response induced by dextran sodium sulfate in mice. Biochem Pharmacol 2012, 84(11):1459-1469.
25. Velásquez-Lopera M.M., Correa L.A., García L.F. Human spleen contains different subsets of dendritic cells and regulatory T lymphocytes. Clin Exp Immunol 2008, 154(1):107-114.
26. Melgar S., Karlsson A., Michaëlsson E. Acute colitis induced by dextran sulfate sodium progresses to chronicity in C57BL/6 but not in BALB/c mice: correlation between symptoms and inflammation. Am J Physiol Gastrointest Liver Physiol 2005, 288(6):G1328-G1338.
27. Dieleman L.A., Palmen M.J., Akol H., Bloemena E., Peña A.S., Meuwissen S.G., et al. Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines. Clin Exp Immunol 1998, 114(3):385-391.
28. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
29. Wang L.X., Lu X.Y., Li H., Yang Q. Study on the cytotoxicity of spleen lymphocytes and immune mechanisms in mice immunized by Mycobacterium tuberculosis H37Ra. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 2007, 23(2):164-167.
30. Kofla-Dłubacz A., Matusiewicz M., Krzesiek E., Noga L., Iwańczak B. Metalloproteinase-3 and -9 as novel markers in the evaluation of ulcerative colitis activity in children. Adv Clin Exp Med 2014, 23(1):103-110.
31. Alex P., Zachos N.C., Nguyen T., Gonzales L., Chen T.E., Conklin L.S., et al. Distinct cytokine patterns identified from multiplex profiles of murine DSS and TNBS-induced colitis. Inflamm Bowel Dis 2009, 15(3):341-352.
32. Zhu J., Wang Y., Yang F., Sang L., Zhai J., Li S., et al. IL-33 alleviates DSS-induced chronic colitis in C57BL/6 mice colon lamina propria by suppressing Th17 cell response as well as Th1 cell response. Int Immunopharmacol 2015, [pii: S1567-5769(15)30090-4]. 10.1016/j.intimp.2015.08.032.
33. Hirota S.A., Ng J., Lueng A., Khajah M., Parhar K., Li Y., et al. NLRP3 inflammasome plays a key role in the regulation of intestinal homeostasis. Inflamm Bowel Dis 2011, 17(6):1359-1372.
34. Viganò E., Mortellaro A. Caspase-11: the driving factor for noncanonical inflammasomes. Eur J Immunol 2013, 43(9):2240-2245.
35. Abbas A.K., Lichtman A.H., Pober J.S. Cellular and Molecular Immunology 2000, WB Saunders, Philadelphia. 4th ed.
36. Axelsson L.G., Midtvedts T., Bylund-Felleniusg A.C. The role of intestinal bacteria, bacterial translocation and endotoxin in dextran sodium sulphate-induced colitis in the mouse. Microb Ecol Health D 1996, 9:225-237.
37. Perše M., Cerar A. Dextran sodium sulphate colitis mouse model: traps and tricks. J Biomed Biotechnol 2012, 2012:718617.
38. López-Posadas R., Ballester I., Abadía-Molina A.C., Suárez M.D., Zarzuelo A., Martínez-Augustin O., et al. Effect of flavonoids on rat splenocytes, a structure-activity relationship study. Biochem Pharmacol 2008, 76(4):495-506.
39. Sánchez-Fidalgo S., Villegas I., Cárdeno A., Talero E., Sánchez-Hidalgo M., Motilva V., et al. Extra-virgin olive oil-enriched diet modulates DSS-colitis associated colon carcinogenesis in mice. Clin Nutr 2010, 29(5):663-673.
40. Sánchez-Fidalgo S., Cárdeno A., Villegas I., Talero E., de la Lastra C.A. Dietary supplementation of resveratrol attenuates chronic colonic inflammation in mice. Eur J Pharmacol 2010, 633(1-3):78-84.
41. Lazarus M., Kubata B.K., Eguchi N., Fujitani Y., Urade Y., Hayaishi O. Biochemical characterization of mouse microsomal prostaglandin E synthase-1 and its colocalization with cyclooxygenase-2 in peritoneal macrophages. Arch Biochem Biophys 2002, 397(2):336-341.
42. Rosillo M.A., Sánchez-Hidalgo M., Cárdeno A., Alarcón de la Lastra C. Protective effect of ellagic acid, a natural polyphenolic compound, in a murine model of Chrons disease. Biochem Pharmacol 2011, 82(7):737-745.
43. Naito Y., Takagi T., Kuroda M., Katada K., Ichikawa H., Kokura S., et al. An orally active matrix metalloproteinase inhibitor, ONO-4817, reduces dextran sulfate sodium-induced colitis in mice. Inflamm Res 2004, 53(9):462-468.
44. Hale L.P., Cianciolo G. Treatment of experimental colitis in mice with LMP-420, an inhibitor of TNF transcription. J Inflamm 2008, 5:4.
45. Bryant C., Fitzgerald K.A. Molecular mechanisms involved in inflammasome activation. Trends Cell Biol 2009, 19(9):455-464.
46. Masters S.L. Specific inflammasomes in complex diseases. Clin Immunol 2013, 147(3):223-228.
47. Cassel S.L., Joly S., Sutterwala F.S. The NLRP3 inflammasome: a sensor of immune danger signals. Semin Immunol 2009, 21(4):194-198.
48. Bauer C., Duewell P., Mayer C., Lehr H.A., Fitzgerald K.A., Dauer M., et al. Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome. Gut 2010, 59(9):1192-1199.
49. Sun Y., Zhao Y., Yao J., Zhao L., Wu Z., Wang Y., et al. Wogonoside protects against dextran sulfate sodium-induced experimental colitis in mice by inhibiting NF-κB and NLRP3 inflammasome activation. Biochem Pharmacol 2015, 94(2):142-154.
50. Zhang J., Fu S., Sun S., Li Z., Guo B. Inflammasome activation has an important role in the development of spontaneous colitis. Mucosal Immunol 2014, 7(5):1139-1150.
51. Bauer C., Duewell P., Lehr H.-A., Endres S., Schnurr M. Protective and aggravating effects of Nlrp3 inflammasome activation in IBD models: influence of genetic and environmental factors. Dig Dis 2012, 30(Suppl. 1):82-90.
52. Zaki M.H., Boyd K.L., Kastan M.B., Lamkanfi M., Kanneganti T.-D. The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis. Immunity 2010, 32(3):379-391.
53. Siegmund B., Lehr H.A., Fantuzzi G., Dinarello C.A. IL-1β-converting enzyme (caspase-1) in intestinal inflammation. Proc Natl Acad Sci U S A 2001, 98(23):13249-13254.
54. Oficjalska K., Raverdeau M., Aviello G., Wade S.C., Hickey A., Sheehan K.M., et al. Protective role for caspase-11 during acute experimental murine colitis. J Immunol 2015, 194(3):1252-1260.
55. Williams T.M., Leeth R.A., Rothschild D.E., McDaniel D.K., Coutermarsh-Ott S.L., Simmons A.E., et al. Caspase-11 attenuates gastrointestinal inflammation and experimental colitis pathogenesis. Am J Physiol Gastrointest Liver Physiol 2015, 308(2):G139-G150.